Search research articles
Contact Us
Filters
Showing results (51-60 of 91) with videos related to
Page
of 10
Sort By:
Annals of Intensive Care
|
February 11, 2023
Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled ASPECT-NP trial
Ignacio Martin-Loeches, Andrew F Shorr, Richard G Wunderink, et al.
JAMA Network Open
|
September 8, 2022
Trends in Postoperative Intensity-Modulated Radiation Therapy Use and Its Association With Survival Among Patients With Incompletely Resected Non-Small Cell Lung Cancer
Brian Yu, Sung Jun Ma, Olivia Waldman, et al.
The Science of the Total Environment
|
January 9, 2022
Relationship between phytoplankton community and water parameters in planted fringing mangrove area in South China
Steven Jing-Liang Xu, Sophie Cheuk-Yan Chan, Brian Yu-Keung Wong, et al.
The Journal of Antimicrobial Chemotherapy
|
July 5, 2022
Ceftolozane/tazobactam for hospital-acquired/ventilator-associated bacterial pneumonia due to ESBL-producing Enterobacterales: a subgroup analysis of the ASPECT-NP clinical trial
David L Paterson, Matteo Bassetti, Mary Motyl, et al.
The Journal of Antimicrobial Chemotherapy
|
March 27, 2020
Lung penetration, bronchopulmonary pharmacokinetic/pharmacodynamic profile and safety of 3 g of ceftolozane/tazobactam administered to ventilated, critically ill patients with pneumonia
Luzelena Caro, David P Nicolau, Jan J De Waele, et al.
International Journal of Antimicrobial Agents
|
February 10, 2021
Pharmacokinetics and Pharmacodynamics of Ceftolozane/Tazobactam in Critically Ill Patients With Augmented Renal Clearance
David P Nicolau, Jan De Waele, Joseph L Kuti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 17, 2016
Are We There Yet? Impact of the First International Standard for Cytomegalovirus DNA on the Harmonization of Results Reported on Plasma Samples
Jutta K Preiksaitis, Randall T Hayden, Yupin Tong, et al.
The Pediatric Infectious Disease Journal
|
August 29, 2018
Pharmacokinetics and Safety of Single Intravenous Doses of Ceftolozane/Tazobactam in Children With Proven or Suspected Gram-Negative Infection
John S Bradley, Jocelyn Y Ang, Antonio C Arrieta, et al.
Cell Host & Microbe
|
June 1, 2022
Impact of a 7-day homogeneous diet on interpersonal variation in human gut microbiomes and metabolomes
Leah Guthrie, Sean Paul Spencer, Dalia Perelman, et al.
Marine Pollution Bulletin
|
August 30, 2024
Differential allelopathic effects of mangrove plants Kandelia obovata and Aegiceras corniculatum on harmful algal species: Potential applications in algal bloom control
Brian Yu-Keung Wong, Yang-Hang Chen, Kai-Hui Cui, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 91) with videos related to
Sort By:
Page
of 10
Annals of Intensive Care
|
February 11, 2023
Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled ASPECT-NP trial
Ignacio Martin-Loeches, Andrew F Shorr, Richard G Wunderink, et al.
JAMA Network Open
|
September 8, 2022
Trends in Postoperative Intensity-Modulated Radiation Therapy Use and Its Association With Survival Among Patients With Incompletely Resected Non-Small Cell Lung Cancer
Brian Yu, Sung Jun Ma, Olivia Waldman, et al.
The Science of the Total Environment
|
January 9, 2022
Relationship between phytoplankton community and water parameters in planted fringing mangrove area in South China
Steven Jing-Liang Xu, Sophie Cheuk-Yan Chan, Brian Yu-Keung Wong, et al.
The Journal of Antimicrobial Chemotherapy
|
July 5, 2022
Ceftolozane/tazobactam for hospital-acquired/ventilator-associated bacterial pneumonia due to ESBL-producing Enterobacterales: a subgroup analysis of the ASPECT-NP clinical trial
David L Paterson, Matteo Bassetti, Mary Motyl, et al.
The Journal of Antimicrobial Chemotherapy
|
March 27, 2020
Lung penetration, bronchopulmonary pharmacokinetic/pharmacodynamic profile and safety of 3 g of ceftolozane/tazobactam administered to ventilated, critically ill patients with pneumonia
Luzelena Caro, David P Nicolau, Jan J De Waele, et al.
International Journal of Antimicrobial Agents
|
February 10, 2021
Pharmacokinetics and Pharmacodynamics of Ceftolozane/Tazobactam in Critically Ill Patients With Augmented Renal Clearance
David P Nicolau, Jan De Waele, Joseph L Kuti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 17, 2016
Are We There Yet? Impact of the First International Standard for Cytomegalovirus DNA on the Harmonization of Results Reported on Plasma Samples
Jutta K Preiksaitis, Randall T Hayden, Yupin Tong, et al.
The Pediatric Infectious Disease Journal
|
August 29, 2018
Pharmacokinetics and Safety of Single Intravenous Doses of Ceftolozane/Tazobactam in Children With Proven or Suspected Gram-Negative Infection
John S Bradley, Jocelyn Y Ang, Antonio C Arrieta, et al.
Cell Host & Microbe
|
June 1, 2022
Impact of a 7-day homogeneous diet on interpersonal variation in human gut microbiomes and metabolomes
Leah Guthrie, Sean Paul Spencer, Dalia Perelman, et al.
Marine Pollution Bulletin
|
August 30, 2024
Differential allelopathic effects of mangrove plants Kandelia obovata and Aegiceras corniculatum on harmful algal species: Potential applications in algal bloom control
Brian Yu-Keung Wong, Yang-Hang Chen, Kai-Hui Cui, et al.
Page
of 10